British Journal of Cancer - Table of Contents alert Volume 113 Issue 10

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 113, Issue 10 (1405-1528) Published online 17 November 2015 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Introducing THE DARWIN CANCER BLOG - "keeping an evolutionary eye on cancer" led by Prof. Mel Greaves and brought to you by BJC. This blog provides a forum for discussing how an evolutionary perspective is changing thinking about cancer and aims to encourage discussion and debate among specialists and general interest readers. Start reading the latest content Minireview Top Big Data: the challenge for small research groups in the era of cancer genomics Aisyah Mohd Noor, Lars Holmberg, Cheryl Gillett and Anita Grigoriadis Br J Cancer 2015 113: 1405-1412; advance online publication, October 22, 2015; 10.1038/bjc.2015.341 Abstract | Full Text Clinical Studies Top Phase I study of afatinib combined with nintedanib in patients with advanced solid tumours Rastislav Bahleda, Antoine Hollebecque, Andrea Varga, Anas Gazzah, Christophe Massard, Eric Deutsch, Nadia Amellal, Françoise Farace, Mahmoud Ould-Kaci, Flavien Roux, Kristell Marzin and Jean-Charles Soria Br J Cancer 2015 113: 1413-1420; advance online publication, October 29, 2015; 10.1038/bjc.2015.374 Abstract | Full Text A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer S H Lim, T W Kim, Y S Hong, S-W Han, K-H Lee, H J Kang, I G Hwang, J Y Lee, H S Kim, S T Kim, J Lee, J O Park, S H Park, Y S Park, H Y Lim, S-H Jung and W K Kang Br J Cancer 2015 113: 1421-1426; advance online publication, October 27, 2015; 10.1038/bjc.2015.371 Abstract | Full Text The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence S M Lagarde, A W Phillips, M Navidi, B Disep, A Immanuel and S M Griffin Br J Cancer 2015 113: 1427-1433; advance online publication, November 10, 2015; 10.1038/bjc.2015.354 Abstract | Full Text Translational Therapeutics Top Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling A R Fetoni, F Paciello, D Mezzogori, R Rolesi, S L M Eramo, G Paludetti and D Troiani Br J Cancer 2015 113: 1434-1444; advance online publication, October 15, 2015; 10.1038/bjc.2015.359 Abstract | Full Text Interplay between cadherins and α2β1 integrin differentially regulates melanoma cell invasion Carole Siret, Chloé Terciolo, Aurelie Dobric, Marie-Christine Habib, Sebastien Germain, Renaté Bonnier, Dominique Lombardo, Véronique Rigot and Frédéric André Br J Cancer 2015 113: 1445-1453; advance online publication, October 29, 2015; 10.1038/bjc.2015.358 Abstract | Full Text Molecular Diagnostics Top P4H9-detected molecule expression on spindle-shaped fibroblasts indicates malignant phenotype of colorectal cancer Shozo Yokoyama, Junji Ieda, Naoyuki Yamamoto, Shunsuke Yamaguchi, Yasuyuki Mitani, Akihiro Takeuchi, Katsunari Takifuji, Tsukasa Hotta, Kenji Matsuda, Takashi Watanabe, John E Shively and Hiroki Yamaue Br J Cancer 2015 113: 1454-1459; advance online publication, October 15, 2015; 10.1038/bjc.2015.363 Abstract | Full Text Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma Steffen Ormanns, Annelore Altendorf-Hofmann, Rene Jackstadt, David Horst, Gerald Assmann, Yue Zhao, Christiane Bruns, Thomas Kirchner and Thomas Knösel Br J Cancer 2015 113: 1460-1466; advance online publication, October 15, 2015; 10.1038/bjc.2015.362 Abstract | Full Text Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer Mahito Miyamae, Shuhei Komatsu, Daisuke Ichikawa, Tsutomu Kawaguchi, Shoji Hirajima, Wataru Okajima, Takuma Ohashi, Taisuke Imamura, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Toshiya Ochiai, Kazuma Okamoto, Hiroki Taniguchi and Eigo Otsuji Br J Cancer 2015 113: 1467-1476; advance online publication, October 27, 2015; 10.1038/bjc.2015.366 Abstract | Full Text Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy Yuji Ikeda, Katsutoshi Oda, Hideki Ishihara, Osamu Wada-Hiraike, Aki Miyasaka, Tomoko Kashiyama, Kanako Inaba, Tomohiko Fukuda, Kenbun Sone, Yoko Matsumoto, Takahide Arimoto, Daichi Maeda, Masako Ikemura, Masahi Fukayama, Kei Kawana, Tetsu Yano, Daisuke Aoki, Yutaka Osuga and Tomoyuki Fujii Br J Cancer 2015 113: 1477-1483; advance online publication, November 10, 2015; 10.1038/bjc.2015.369 Abstract | Full Text TIM-4 promotes the growth of non-small-cell lung cancer in a RGD motif-dependent manner Qianqian Zhang, Hongxing Wang, Xiaodong Wu, Bing Liu, Wen Liu, Rong Wang, Xiaohong Liang, Chunhong Ma and Lifen Gao Br J Cancer 2015 113: 1484-1492; advance online publication, October 29, 2015; 10.1038/bjc.2015.323 Abstract | Full Text Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer Yusuke Takahashi, Koji Sakaguchi, Hirotoshi Horio, Kyoko Hiramatsu, Shunsuke Moriya, Keiichi Takahashi and Masao Kawakita Br J Cancer 2015 113: 1493-1501; advance online publication, October 27, 2015; 10.1038/bjc.2015.349 Abstract | Full Text Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression R Böttcher, D J P Henderson, K Dulla, D van Strijp, L F Waanders, G Tevz, M L Lehman, D Merkle, G J L H van Leenders, G S Baillie, G Jenster, M D Houslay and R Hoffmann Br J Cancer 2015 113: 1502-1511; 10.1038/bjc.2015.335 Abstract | Full Text Genetics & Genomics Top Polygenic susceptibility to testicular cancer: implications for personalised health care Kevin Litchfield, Jonathan S Mitchell, Janet Shipley, Robert Huddart, Ewa Rajpert-De Meyts, Niels E Skakkebæk, Richard S Houlston and Clare Turnbull Br J Cancer 2015 113: 1512-1518; advance online publication, October 13, 2015; 10.1038/bjc.2015.334 Abstract | Full Text Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis Feng-Che Kuan, Liang-Tseng Kuo, Min-Chi Chen, Cheng-Ta Yang, Chung-Sheng Shi, David Teng and Kuan-Der Lee Br J Cancer 2015 113: 1519-1528; advance online publication, October 13, 2015; 10.1038/bjc.2015.356 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.